Immunosuppression for interstitial lung disease in systemic sclerosis - novel insights and opportunities for translational research.
作者信息
Hudson Marie, Steele Russell, Baron Murray
机构信息
Jewish General Hospital, Lady Davis Institute for Medical Research and McGill University, Montreal, QC, Canada,
出版信息
J Cell Commun Signal. 2012 Dec;6(4):187-90. doi: 10.1007/s12079-012-0172-4. Epub 2012 Aug 3.
Abstract
摘要
相似文献
1
Immunosuppression for interstitial lung disease in systemic sclerosis - novel insights and opportunities for translational research.系统性硬化症中间质性肺病的免疫抑制——转化研究的新见解与机遇
J Cell Commun Signal. 2012 Dec;6(4):187-90. doi: 10.1007/s12079-012-0172-4. Epub 2012 Aug 3.
2
Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.系统性硬皮病相关间质性肺病的治疗：现有和新兴疗法的综述。
Ann Am Thorac Soc. 2016 Nov;13(11):2045-2056. doi: 10.1513/AnnalsATS.201606-426FR.
3
New developments in scleroderma interstitial lung disease.硬皮病相关性间质性肺病的新进展
Curr Opin Rheumatol. 2005 Nov;17(6):737-45. doi: 10.1097/01.bor.0000181534.67685.5a.
4
Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.与系统性自身免疫性疾病相关的进行性纤维性间质性肺病。
Clin Rheumatol. 2019 Oct;38(10):2673-2681. doi: 10.1007/s10067-019-04720-0. Epub 2019 Aug 19.
5
Interstitial lung disease pathology in systemic sclerosis.系统性硬化症中的间质性肺疾病病理学
Ther Adv Musculoskelet Dis. 2021 Jul 17;13:1759720X211032437. doi: 10.1177/1759720X211032437. eCollection 2021.
6
[New developments in systemic sclerosis-associated interstitial lung disease].系统性硬化症相关间质性肺疾病的新进展
Rev Med Suisse. 2020 Nov 18;16(715):2218-2223.
7
Interstitial lung disease in Systemic sclerosis: insights into pathogenesis and evolving therapies.系统性硬化症中的间质性肺疾病：发病机制及新兴疗法的见解
Mediterr J Rheumatol. 2018 Sep 27;29(3):140-147. doi: 10.31138/mjr.29.3.140. eCollection 2018 Sep.
8
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).系统性硬化症患者的间质性肺病：基于个体化医学的系统性硬化症相关间质性肺病（SSc-ILD）预测和药物筛选模型。
Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020.
9
Structural features of interstitial lung disease in systemic sclerosis.
Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):706-13. doi: 10.1164/ajrccm/144.3_Pt_1.706.
10
Association of Serum Homocysteine Level and Interstitial Lung Disease in Systemic Sclerosis: A Case-control Study.系统性硬化症患者血清同型半胱氨酸水平与间质性肺疾病的关联：一项病例对照研究。
Curr Rheumatol Rev. 2019;15(1):74-78. doi: 10.2174/1573397114666180628162907.
引用本文的文献
1
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.免疫抑制治疗与系统性硬化症中轻度间质性肺疾病病程的关联
Rheumatology (Oxford). 2020 May 1;59(5):1108-1117. doi: 10.1093/rheumatology/kez407.
2
Long-term effects of immunosuppressive therapy on lung function in scleroderma patients.硬皮病患者免疫抑制治疗对肺功能的长期影响。
Clin Rheumatol. 2018 Nov;37(11):3043-3050. doi: 10.1007/s10067-018-4266-0. Epub 2018 Aug 24.
3
Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.与类风湿关节炎间质性肺病发生和预后不良相关的临床特征。
Korean J Intern Med. 2019 Mar;34(2):434-441. doi: 10.3904/kjim.2016.349. Epub 2017 Mar 28.
4
Immunosuppression for interstitial lung disease in systemic sclerosis.系统性硬皮病的间质性肺疾病的免疫抑制治疗。
Eur Respir Rev. 2013 Sep 1;22(129):236-43. doi: 10.1183/09059180.00001813.
本文引用的文献
1
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis.用于预测系统性硬化症中存在间质性肺病的临床决策规则。
Arthritis Care Res (Hoboken). 2012 Apr;64(4):519-24. doi: 10.1002/acr.21583.
2
Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.预测硬皮病相关间质性肺疾病的治疗结果和反应亚组。
Arthritis Rheum. 2011 Sep;63(9):2797-808. doi: 10.1002/art.30438.
3
Observational data to study medication outcomes in systemic sclerosis.
J Rheumatol. 2011 Mar;38(3):575-7. doi: 10.3899/jrheum.100386.
4
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.早期系统性硬化症中肺间质疾病的预测因素：GENISOS 队列的前瞻性纵向研究。
Arthritis Res Ther. 2010;12(5):R166. doi: 10.1186/ar3125. Epub 2010 Sep 2.
5
The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study.接受抗逆转录病毒治疗的HIV感染患者中HIV易感性检测与生存情况的关联：一项队列研究。
Ann Intern Med. 2009 Jul 21;151(2):73-84. doi: 10.7326/0003-4819-151-2-200907210-00003.
6
De testimonio: on the evidence for decisions about the use of therapeutic interventions.《关于治疗干预措施使用决策的证据》
Lancet. 2008 Dec 20;372(9656):2152-61. doi: 10.1016/S0140-6736(08)61930-3.
7
Interstitial lung disease in systemic sclerosis: a simple staging system.系统性硬化症中的间质性肺疾病：一种简易分期系统。
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27.
8
The effect of epoetin dose on hematocrit.促红细胞生成素剂量对血细胞比容的影响。
Kidney Int. 2008 Feb;73(3):347-53. doi: 10.1038/sj.ki.5002688. Epub 2007 Nov 14.
9
Incidence and prevalence of systemic sclerosis: a systematic literature review.系统性硬化症的发病率和患病率：一项系统文献综述
Semin Arthritis Rheum. 2008 Feb;37(4):223-35. doi: 10.1016/j.semarthrit.2007.05.003. Epub 2007 Aug 9.
10
Changes in causes of death in systemic sclerosis, 1972-2002.1972年至2002年系统性硬化症的死因变化
Ann Rheum Dis. 2007 Jul;66(7):940-4. doi: 10.1136/ard.2006.066068. Epub 2007 Feb 28.
Zotero 插件